ARCHIVES

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Gets 41.258 Bil. In Final FY 1986 Appropriations

November 29, 1985

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions.

March 9, 2007

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984